Skip to main content
. 2014 Jul 17;111(7):1275–1284. doi: 10.1038/bjc.2014.399

Figure 4.

Figure 4

DFS and OS curves stratified by combined analysis of intratumoural hENT1 and RRM1 expression. AGC (+) indicates subgroups of patients who received adjuvant gemcitabine-based chemotherapy; AGC (−) indicates subgroups of patients who did not receive adjuvant gemcitabine-based chemotherapy. (A) DFS curves in AGC (+) patients (P=0.003). (B) DFS curves in AGC (−) patients (P=0.778). (C) OS curves in AGC (+) patients (P=0.015). (D) OS curves in AGC (−) patients (P=0.994).